Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.

@article{BeyerWestendorf2014RatesMA,
  title={Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.},
  author={Jan Beyer‐Westendorf and Kati F{\"o}rster and Sven Pannach and Franziska Ebertz and Vera Gelbricht and Christoph Thieme and Franziska Michalski and Christina Koehler and Sebastian Werth and Kurtuluş Sahin and Luise Tittl and Ulrike Haensel and Norbert Weiss},
  journal={Blood},
  year={2014},
  volume={124 6},
  pages={
          955-62
        }
}
  • Jan Beyer‐Westendorf, Kati Förster, +10 authors Norbert Weiss
  • Published in Blood 2014
  • Medicine
  • Worldwide, rivaroxaban is increasingly used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism, but little is known about rivaroxaban-related bleeding complications in daily care. Using data from a prospective, noninterventional oral anticoagulation registry of daily care patients (Dresden NOAC registry), we analyzed rates, management, and outcome of rivaroxaban-related bleeding. Between October 1, 2011, and December 31, 2013, 1776 rivaroxaban patients were… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 193 CITATIONS, ESTIMATED 45% COVERAGE

    Neue Einsichten durch Real-World-Daten zu oralen Non-Vitamin-K-Antikoagulanzien

    VIEW 5 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Characteristics, Management, and Outcomes of Patients with Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban

    VIEW 6 EXCERPTS
    CITES BACKGROUND, RESULTS & METHODS
    HIGHLY INFLUENCED

    Direct Oral Anticoagulants in the Treatment of Venous Thromboembolic Disease.

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.

    VIEW 4 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    NOACs for treatment of venous thromboembolism in clinical practice.

    VIEW 4 EXCERPTS
    CITES RESULTS & BACKGROUND
    HIGHLY INFLUENCED

    FILTER CITATIONS BY YEAR

    2014
    2020

    CITATION STATISTICS

    • 12 Highly Influenced Citations

    • Averaged 31 Citations per year from 2017 through 2019

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 26 REFERENCES

    European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

    • Hein Heidbuchel, Peter Verhamme, +6 authors Paulus Kirchhof
    • Medicine
    • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
    • 2013

    Anticoagulation-Related Intracranial Hemorrhages

    VIEW 1 EXCERPT